TNDM

Tandem Diabetes Care Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↑ 6/10
  • Value↓ 2/10
Tandem Diabetes Care sales and earnings growth
TNDM Growth
Good
  • Revenue Y/Y↓ 1.70%
  • EPS Y/Y↑ 50.00%
  • FCF Y/Y↓ 4.11%
Tandem Diabetes Care gross and profit margin trends
TNDM Profitability
Fair
  • Gross margin ↑ 54.90%
  • EPS margin↓ -9.20%
  • ROIC 5Y↓ -14.62%
Tandem Diabetes Care net debt vs free cash flow
TNDM Risk
Poor
  • Debt / Equity↑ 5.5
  • Debt / FCF↑ 152.6
  • Interest coverage↓ -10.9

Tandem Diabetes Care stock volatility is in-line with the overall market. We give it a Poor risk rating.

↗ More Medical Devices stocks